cardiovascular deviceshigh engagement
Medtronic and Boston Scientific push cardiovascular device evidence forward
Multiple studies center on device-enabled cardiovascular and neurovascular care, including Medtronic's Intrepid TTVR trial, Boston Scientific's FARAPULSE registry, Medtronic's RECANOVA stroke registry, and a Boston Scientific catheter safety alert. Together they reflect active clinical validation and post-market scrutiny across high-value device platforms.
Draft a post from this →neuromodulationlow engagement
New studies probe brain stimulation and fine motor measurement
Smaller clinical studies focus on neurologic stimulation and functional measurement, including deep brain stimulation for focal hand dystonia and a dynamometry protocol for finger extensor strength. These signals point to continued innovation in quantifying motor function and using implanted or procedural neuromodulation approaches.
Draft a post from this →oncology trialshigh engagement
Cancer trial pipeline widens with biomarker guided combination studies
Several recruiting and active oncology trials test new combinations or biomarker-guided treatment strategies, including HER2-positive endometrial cancer, Hodgkin lymphoma, pMMR TP53-mutated endometrial cancer, aggressive sarcomas, bladder/urothelial cancer, hepatocellular carcinoma, and ovarian granulosa cell tumors. While these are primarily therapeutic studies, they are highly relevant to medical device watchers because they define clinical settings where diagnostic, surgical, infusion, and monitoring devices are used and validated.
Draft a post from this →FDAmedium engagement
FDA enforcement pressure keeps device safety in focus
Regulatory attention remains a major theme, with a Boston Scientific catheter issue alert and an article on FDA's 2026 enforcement priorities. Together they highlight continued scrutiny of device quality systems, product safety, and compliance expectations.
Draft a post from this →NIH fundinglow engagement
NIH dollars keep backing the research that feeds medtech
NIH awards across multiple institutions fund work in maternal cardiovascular outcomes, Parkinson's biomarkers, sleep and schizophrenia, women's health, pregnancy alcohol use, and a Copaxone patch concept for multiple sclerosis. Most are not pure device stories, but they reinforce the broader translational research environment that feeds diagnostics, wearables, patches, and other medtech innovations.
Draft a post from this →